TGA publishes AusPAR for Nuvigil (armodafinil)

9 June 2016 - The TGA has published an AusPAR for Teva's Nuvigil (armodafinil). ...

Read more →

TGA publishes 2 new AusPARs

6 June 2016 - The TGA has published AusPARs for talimogene laherparepvec (Imlygic) & naloxegol oxalate (Movantik). ...

Read more →

TGA approves lesinurad (Zurampic)

2 June 2016 - The TGA has approved Astra Zeneca's lesinurad (Zurampic). ...

Read more →

TGA approves new indication for Perjeta

1 June 2016 - The TGA has approved a new use for Roche's Perjeta (pertuzumab). ...

Read more →

Prescription medicines: TGA annual report for 2015 (part 3 - timelines)

26 May 2016 - The TGA claims it takes, on average, 12 months for the agency to register a new ...

Read more →

TGA updates prescription medicine clinical units

26 May 2016 - The TGA conducts a minor reallocation of prescription medicine authorisation unit work streams. ...

Read more →

TGA approves idarucizumab (Praxbind)

20 May 2016 - The TGA approved idarucizumab (Praxbind) on 11 May 2016. ...

Read more →

TGA approves alirocumab (Praluent)

19 May 2016 - The TGA approved alirocumab (Praluent) on 17 May 2016. ...

Read more →

Prescription medicines: new or extended uses approved by the TGA (May 2016)

19 May 2016 - The TGA has approved new indications for four medicines so far this month. ...

Read more →

Prescription medicines: new or extended uses approved by the TGA

17 May 2016 - The TGA has published a list of the medicines it approved for new uses (new indications) ...

Read more →

TGA publishes AusPAR for Repatha (evolocumab)

16 May 2016 - An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the ...

Read more →

April 2016 NCE registrations - TGA

2 May 2016 - The TGA registered two new chemical entities (medicines) and two new blood products in April 2016. ...

Read more →

AusPARs user survey

2 May 2016 - The TGA would like to know what you think about the AusPARs for prescription medicines. ...

Read more →

TGA publishes 2 new AusPARs

12 April 2016 - The TGA has published Australian Public Assessment Reports (AusPARs) for eltrombopag olamine (Revolade) and the biosimilar for ...

Read more →

March 2016 NCE registrations - TGA

7 April 2016 - The TGA registered three new medicines and one new combination product in March 2016: lumacaftor with ...

Read more →